WuXi Biologics (Cayman) Inc. (WXXWY)
OTCMKTS · Delayed Price · Currency is USD
10.23
+0.41 (4.18%)
Feb 10, 2026, 3:58 PM EST
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of $21.19 billion as of February 10, 2026. Its market cap has increased by 115.21% in one year.
Market Cap
21.19B
Enterprise Value
20.73B
Revenue
2.80B
Ranking
n/a
PE Ratio
36.18
Stock Price
$10.23
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 4.11B to 21.19B, an increase of 415.78%. That is a compound annual growth rate of 20.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 21.19B | 26.91% |
| Dec 31, 2025 | 16.70B | 79.88% |
| Dec 31, 2024 | 9.28B | -41.99% |
| Dec 29, 2023 | 16.00B | -50.63% |
| Dec 30, 2022 | 32.41B | -35.36% |
| Dec 31, 2021 | 50.14B | -7.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 406.62M |
| CytoDyn | 317.38M |
| Silence Therapeutics | 224.36M |
| Vaxart | 145.67M |
| HST Global | 139.70M |
| BioStem Technologies | 104.83M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |